Literature DB >> 23887597

Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and non-metastatic colorectal cancer: reply.

Josep Marti1, Josep Fuster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23887597     DOI： 10.1007/s00268-013-2166-7

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  1 in total

1.  Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer.

Authors:  Josep Martí; Josep Fuster; Anna M Solà; Georgina Hotter; Rafael Molina; Amalia Pelegrina; Joana Ferrer; Ramon Deulofeu; Constantino Fondevila; Juan Carlos García-Valdecasas
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352
  1 in total
  3 in total

1.  A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.

Authors:  Laurence Duvillard; Pablo Ortega-Deballon; Abderrahmane Bourredjem; Marie-Lorraine Scherrer; Georges Mantion; Jean-Baptiste Delhorme; Sophie Deguelte-Lardière; Jean-Michel Petit; Claire Bonithon-Kopp
Journal:  BMC Cancer       Date:  2014-12-03       Impact factor: 4.430

Review 2.  Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner?

Authors:  Brigitte Bauvois; Santos A Susin
Journal:  Cancers (Basel)       Date:  2018-09-18       Impact factor: 6.639

Review 3.  Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma.

Authors:  Kai Che; Wenkai Han; Mingxin Zhang; Haitao Niu
Journal:  Oncol Lett       Date:  2020-12-24       Impact factor: 2.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.